MAIA Biotechnology Inc. Cash Flow-to-Debt Ratio
MAIA Biotechnology Inc. cash flow-to-debt ratio. MAIA Biotechnology Inc. (MAIA) has a Cash Flow-to-Debt Ratio of -0.70x as of March 2026, meaning its operating cash flow of $-5.31 Million could theoretically repay -1% of its total liabilities ($7.56 Million) in one year. See MAIA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of MAIA Biotechnology Inc. (2019–2025)
Cash flow-to-debt ratio of MAIA Biotechnology Inc. from 2019 to 2025. Historical debt coverage capacity for MAIA Biotechnology Inc. across 7 annual periods. See MAIA net asset quality index to measure how much of total assets are equity-financed.
MAIA Biotechnology Inc. Cash Flow-to-Debt Ratio by Year (2019–2025)
MAIA Biotechnology Inc. cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for MAIA Biotechnology Inc.. For the full cash flow conversion analysis, see MAIA Biotechnology Inc. operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.57x | $-18.84 Million | $7.33 Million | ▼ -6.8% |
| 2024 | -2.41x | $-15.70 Million | $6.52 Million | ▼ -30.6% |
| 2023 | -1.84x | $-13.07 Million | $7.09 Million | ▲ +46.4% |
| 2022 | -3.44x | $-12.10 Million | $3.51 Million | ▼ -79.2% |
| 2021 | -1.92x | $-4.12 Million | $2.15 Million | ▼ -146.2% |
| 2020 | -0.78x | $-1.84 Million | $2.36 Million | ▲ +79.6% |
| 2019 | -3.82x | $-1.57 Million | $409.74K | — |